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Recent studies have shown enhanced antitumor efficacy with adenoviruses that either lack E1B-19K or overexpress E3-11.6K (also
known as adenoviral death protein). E1B-19K is a well-characterized anti-apoptotic protein, and viruses with E1B-19K deletions show
increased cytopathicity. However, the mechanism of cell killing by E3-11.6K, which plays an important role in killing infected cells and
virion release, is not well characterized. To understand the mechanism of cell killing following E3-11.6K overexpression, we constructed a
recombinant adenovirus, Ad-ME, by introducing viral major late promoter upstream of the E3-11.6K sequence. Similar to the E1B-19K-
deleted virus, E1B/19K, Ad-ME induced cell death to a greater extent than the wild-type virus. Cell shrinkage, membrane blebbing,
activation of caspases 3 and 9, cleavage of poly(ADP-ribose)polymerase (PARP), DNA degradation, and ratio of ADP to ATP in Ad-ME-
infected cells indicated that apoptosis contributes to cell death following E3-11.6K overexpression. However, the levels of activation of
caspases 3 and 9 were lower in cells infected with Ad-ME compared to those infected with E1B/19K. Furthermore, cell killing by Ad-ME
was not effectively inhibited by Z-VAD-FMK, a general caspase inhibitor. Taken together, our results suggest both caspase-dependent and
caspase-independent mechanisms of cell killing due to overexpression of E3-11.6K.
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Introduction overexpression of viral protein(s) involved in inductionA number of replicating adenoviruses are currently
undergoing preclinical and clinical evaluation for cancer
therapy (Kirn, 2000, 2001). To achieve maximum efficacy
with replicating adenoviruses, efficient killing of tumor
cells and rapid spread of the virus within a tumor are
essential. Strategies evaluated to achieve rapid spread
include specific alterations in the viral genome and incor-
poration of transgenes (Alemany et al., 2000). Because of
limitations in the size and type of transgene that can be
inserted without compromising the replication potential of
the virus, engineering the viral regulatory pathways may be
more desirable. Alterations evaluated within the viral
genome to enhance the oncolytic potency include func-
tional inactivation of anti-apoptotic viral protein(s) and0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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During adenovirus infection, expression of E1A induces
both proliferation and apoptosis (White, 1998). While the
E1B-19K gene product blocks apoptosis induced by E1A
and prevents premature killing of infected cells (White,
1998; White et al., 1986), E3-11.6K, also known as adeno-
viral death protein (Tollefson et al., 1996a, 1996b), and
E4orf4 (Lavoie et al., 1998; Marcellus et al., 1998, 2000)
promote cell death following replication and assembly of the
virus. Consistent with the anti-apoptotic function of E1B-
19K, E1B-19K-deleted viruses were found to induce apop-
tosis very efficiently, resulting in the faster spread of the
virus than the wild type (White et al., 1986). AdH5dl118, a
virus that lacks expression of both E1B-19K and E1B-55K
proteins, and Ad337, a virus that lacks E1B-19K, showed
enhanced cytolytic activity on tumor cell lines in vitro and in
vivo (Duque et al., 1999; Harrison et al., 2001).
Overexpression of E3-11.6K late in the infection as a
means to enhance the cytolytic activity without interfering in
virus replication has also been investigated (Doronin et al.,
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low levels at early times in the lytic cycle, but synthesized in
large amounts from mRNAs derived from the major late
promoter (Tollefson et al., 1992). E3-11.6K overexpression
and enhanced oncolytic activity in xenograft tumor models
were achieved upon removal of all other open reading frames
in the E3 region except that of E3-11.6K in the virus, KD1,
which also contained deletions in the E1A gene that abol-
ishes binding of E1A to p300/CBP and retinoblastoma
protein (Doronin et al., 2000). Overexpression of E3-11.6K
and increased in vitro and in vivo oncolytic activity were also
achieved by using an extra copy of the viral major late
promoter inserted in the E3 region upstream of the E3-11.6K
coding sequence (Ramachandra et al., 2001). The use of the
major late promoter, which becomes active after the onset of
DNA replication, couples E3-11.6K overexpression and cell
killing to viral DNA replication, and thus provides another
level of control in oncolytic viruses (Ramachandra et al.,
2001). Recent studies have also shown that adenovirus
mutants that overexpress E3-11.6K produce early cytopathic
effect, early cell lysis, large plaques, and increased cell-to-
cell spread (Doronin et al., 2003).
To fully exploit the usefulness of E3-11.6K in the context
of conditionally replicating adenoviruses, a better under-
standing of the mechanism of cell killing in viruses that
overexpress E3-11.6K is needed. In the present study, we
constructed a recombinant adenovirus capable of overex-
pressing E3-11.6K and characterized its activities in several
assays. Results indicate that overexpression of E3-11.6K
leads to potent cell killing that results from both caspase-
dependent and caspase-independent mechanisms.Results
Construction of an adenovirus that overexpresses E3-11.6K
To delineate the mode of cell killing upon E3-11.6K
overexpression, a virus-encoding E3-11.6K controlled by an
extra copy of the major late promoter from adenovirus type
2 was constructed in a viral backbone with a partial E3Fig. 1. Schematic illustration of the structures of replicating adenoviruses used in
open reading frames in the E3 region. To achieve E3-11.6K overexpression, E3
adenovirus type 2 was inserted in the E3 region in Ad-ME.deletion as in dl327 (Fig. 1). E1B/19K, a virus with
inactivating mutations in E1B-19K (Marcellus et al.,
1996) that was previously shown to be one of the most
cytopathic viruses, and dl309, the parental virus for E1B/
19K (Fig. 1) were also included in the studies.
Overexpression of E3-11.6K results in potent cell killing
activity
A549 cells were infected with Ad-ME, the parental virus
dl327, and other control viruses. Expression of E3-11.6K
was determined by immunoblot analysis (Fig. 2A). Expres-
sion of E3-11.6K from Ad-ME was considerably higher
than that observed with the wild-type adenovirus, dl309 or
E1B/19K, indicating overexpression due to insertion of the
major late promoter immediately upstream of the E3-11.6K-
coding sequence. As expected, E3-11.6K expression was
not detected upon infection of cells with dl327 (Fig. 2A).
Microscopic observation of infected cells showed greater
cytopathic effect in cells infected with Ad-ME and E1B/
19K compared to those infected with dl327, dl309, or the
wild type. Increased cytopathicity was also confirmed by
determining viability of infected cells by performing MTS
assays. Results indicate that Ad-ME was more potent than
the parental dl327 or wild-type virus, confirming increased
lytic activity due to E3-11.6K overexpression (Fig. 2B). As
expected, dl327 that lacks E3-11.6K was the least cytolytic
among the viruses examined. The cytolytic activity of Ad-
ME was comparable to that of E1B/19K (Fig. 2B), and
similar results were obtained when other cell lines were used
(data not shown).
Annexin V staining assay was then performed to deter-
mine whether increased cell killing following E3-11.6K
overexpression is due to induction of apoptosis. The
annexin V staining assay, a widely used method to deter-
mine apoptosis, detects exposure of phosphatidylserine on
the cell surface (Vermes et al., 1995). Because annexin V
binds to cells undergoing death by both apoptosis and
necrosis, annexin V assay is routinely performed in con-
junction with propidium iodide (PI) staining of unfixed
cells, and cells that are annexin V positive and PI negativethe study. Differences among viruses are shown indicating only the intact
-11.6K cDNA under the control of the major late promoter (MLP) from
Fig. 2. Overexpression of E3-11.6K leads to greater cell killing. (Panel A)
A549 cells infected with indicated viruses at 1  108 particles/ml for 1 h
were harvested 48 h postinfection. Cell lysates were subjected to
immunoblot analysis for E3-11.6K. (Panel B) Dose-dependent reduction
in cell viability following infection of A549 cells with wild-type Ad5 (w),
dl327 (D), Ad-ME (E), dl309 (o), and E1B/19K (.) is shown. Results
are depicted as a function of the value determined for the uninfected
negative control sample. (Panel C) Indicated viruses were used to infect
A549 cells at 1  107 particles or SK-Hep1 cells at 5  108 particles/ml for
1 h. Cells were harvested by trypsinization at 48 h after infection and the
extent of cell killing was determined by annexin V staining and flow
cytometric analysis.
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staining of A549 and SK-Hep1 cells at 48 h after infection
showed a greater than three-fold increase in annexin V-
positive cells upon infection with Ad-ME or E1B/19K
compared to the parental viruses dl327 and dl309 (Fig. 2C).
However, annexin V-positive cells in all treatments were
also stained with PI (data not shown). Staining with both
annexin V and PI was also observed when analysis was
performed at early times after infection. Because PI staining
was also observed in cells infected with E1B/19K that has
previously been shown to induce apoptosis (Marcellus et al.,
1996), we decided to perform additional assays to further
characterize cell killing due to E3-11.6K overexpression.
Induction of apoptosis following E3-11.6K overexpression
Cell shrinkage and membrane blebbing are hallmarks of
apoptosis (Vermes et al., 2000). Microscopic observation of
cells showed that infection with either E1B/19K or Ad-ME
but not with parental viruses dl309 and dl327 resulted in cell
shrinkage (as opposed to cell swelling during necrosis) and
membrane blebbing (Fig. 3A). Light scatter analysis of
infected cells by flow cytometry also revealed a decrease
in forward scatter and increase in side scatter in Ad-ME-
infected cells compared to those with parental dl327 (Fig.
3B, see lower left quadrant for clarity). Such decrease in
forward scatter due to cell shrinkage and increase in side
scatter because of cellular granularity are known to occur in
cells undergoing apoptosis (Sandstrom et al., 2000).
To confirm that E3-11.6K overexpression indeed resulted
in apoptosis, activation of caspases was determined. Cells
were harvested at different times after infection, and the
extent of cell killing was determined by annexin V staining
and caspase activation by fluorimetric assays. Results indi-
cated induction of early and a greater than three-fold
increase in annexin V-positive cells following infection with
Ad-ME or E1B/19K compared to control viruses. In
agreement with a lack of cell killing (Fig. 4A), activation
of both caspase 3 (Fig. 4B) and caspase 9 (Fig. 4C) was not
detected in mock-infected cells or cells infected with control
viruses dl327 and dl309 at the doses examined. In compa-
rison to dl327, Ad-ME activated caspase 3 by four-fold and
caspase 9 by three-fold at 40 h postinfection, indicating
activation of caspases due to E3-11.6K overexpression.
Interestingly, although the extent and kinetics of cell killing
by E1B/19K were similar to that observed with Ad-ME
(Fig. 4A), activation of both caspase 3 (Fig. 4B) and caspase
9 (Fig. 4C) by E1B/19K was at least two-fold higher than
that observed with Ad-ME 40 h after infection. In similar
fluorimetric assays, activation of caspase 8 was not observed
in cells infected with any of the viruses (data not shown).
Caspase activation was confirmed by examining the
cleavage of procaspases 3 and 9 to active forms by immu-
noblot analysis (Fig. 5A). In mock and control virus-
infected cells, both procaspases 3 and 9 were not processed,
whereas in E1B/19K- and Ad-ME-infected cells, both
Fig. 3. Morphology of cells infected with adenoviruses. (Panel A) SK-Hep1 cells were infected with indicated viruses at 5  108 particles/ml for 1 h and
observed under the microscope at 2 days postinfection (Panel A) or trypsinized and subjected to flow cytometry to determine forward and side light scatter
(Panel B). Arrows in Panel A show cell shrinkage and membrane blebbing in cells infected with Ad-ME or E1B/19K.
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these enzymes (Fig. 5A, top two panels). Although both
E1B/19K and Ad-ME induced processing of procaspase 3
into the 17K product, the 12K product was apparent only in
cells infected with E1B/19K (Fig. 5A, top panel). Failure
to detect the 12 K product in Ad-ME-infected cells could be
due to the lower level of activation as indicated by a higher
level of uncleaved form in Ad-ME-infected cells than in
E1B/19K-infected cells (Fig. 5A, top panel). Consistent
with the lack of caspase 8 activation in fluorimetric assays,
cleavage of procaspase 8 was not observed in immunoblot
analysis with any of the viruses (Fig. 5A, bottom panel).
Activation of caspase 3 leads to cleavage of poly(ADP-
ribose)polymerase (PARP) into 85 and 29 K products
(Tewari et al., 1995). In mock and parental virus-infected
cells, a low level of 29K product was observed (Fig. 5B, top
panel). In contrast, a higher level of 29 K product of PARPwas observed in cells infected with E1B/19K or Ad-ME
(Fig. 5B, top panel). Apoptosis of infected cells was also
examined by monitoring the fragmentation of cellular DNA.
Infection with E1B/19K and Ad-ME, but not with control
viruses, resulted in a similar DNA fragmentation pattern
(Fig. 5B, bottom panel).
Measurement of ADP/ATP ratio to characterize cell death
induced by E3-11.6K overexpression
Because apoptosis is an active-energy-dependent process
requiring functional mitochondria, cells show an increase in
the levels of cellular ADP without an appreciable drop in
ATP during the onset of apoptosis (Bradbury et al., 2000).
Therefore, we measured the ADP/ATP ratio to further
characterize cell killing due to E3-11.6K overexpression
(Fig. 6). The ADP/ATP ratio has been shown to distinguish
Fig. 4. Kinetics of cell killing and activation of caspases 3 and 9. SK-Hep1
cells were mock infected (5) or infected with dl327 (D), Ad-ME (E),
dl309 (o), and E1B/19K (.) at 5  108 particles/ml for 1 h and harvested
at the indicated time after infection. Cells were either trypsinized and
subjected to annexin V staining and flow cytometric analysis (Panel A), or
analyzed for activation of caspase 3 (Panel B) and caspase 9 (Panel C) using
specific caspase substrates that become fluorescent upon cleavage. Data
from a representative experiment are shown.
Fig. 5. Activation of caspases, cleavage of PARP, and DNA degradation.
SK-Hep1 cells were mock infected or infected with indicated viruses at 5 
108 particles/ml for 1 h and harvested at 48 h postinfection. (Panel A) Cell
lysates were subjected to immunoblot analysis for caspases 3, 9, and 8.
(Panel B) Cell lysates were subjected to immunoblot analysis to determine
PARP cleavage (top). Low molecular weight DNA was isolated and
subjected to agarose gel electrophoresis (bottom).
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cultured cell lines (Bradbury et al., 2000; Cox et al., 2001;
Simmons et al., 2001). Upon progression of the apoptotic
process into secondary necrosis, the ADP levels increase
further as a result of ATP hydrolysis. As a result, cells
undergoing apoptosis exhibit the ratio of ADP to ATP
between 0.11 and 0.7 with greater ratio indicating higher
percentage of apoptosis when compared to a ratio of lessthan 0.11 for proliferating cells. In primary necrosis, ATP
levels fall rapidly as a result of exposure to high concen-
trations of toxic agents with a corresponding increase in
cellular ADP resulting in an ADP/ATP ratio of >10.0
(Bradbury et al., 2000). Results presented in Fig. 6 show
a virus dose-dependent increase in the ADP/ATP ratio with
a maximum level of around 0.4 in cells infected with either
E1b-19K or Ad-ME, indicating induction of apoptosis.
Uninfected cells and cells infected with dl327 at the highest
dose (1  109 particles/ml) exhibited a ratio of 0.06 and
0.05 (F0.009), respectively, suggesting proliferation or
lack of apoptosis. ADP/ATP ratio of 0.10 (F0.03) support-
ing apoptosis was also observed upon expression of p53, a
well-characterized pro-apoptotic protein, using a replica-
tion-defective adenovirus vector at 1  109 particles/ml.
Fig. 6. ADP/ATP ratio supports induction of apoptosis in cells infected with
a virus with E3-11.6K overexpression. SK-Hep1 cells were infected with
the indicated viruses at indicated doses for 1 h and harvested 48 h
postinfection. The ADP/ATP ratio as an indicator of cell proliferation,
necrosis, and apoptosis was measured. Cells undergoing apoptosis exhibit
the ratio of ADP to ATP of between 0.11 and 0.7 with greater ratio
indicating higher percentage of apoptosis when compared to a ratio of less
than 0.11 for proliferating cells.
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and Ad-ME
Z-VAD-FMK is a general inhibitor of caspases (Zhu
et al., 1995) that blocks or delays apoptosis resulting from
a diverse set of signals. Treatment of infected cells with Z-
VAD-FMK followed by annexin V staining indicated that
cell death mediated by E1B/19Kwas effectively inhibited
by Z-VAD-FMK (greater than 50% inhibition) (Fig. 7A).
However, there was only a modest inhibition of Ad-ME-
induced cell killing by Z-VAD-FMK (less than 15% inhi-
bition) (Fig. 7B).Fig. 7. Cell killing induced by a virus with E3-11.6K overexpression is not
inhibited by a general caspase inhibitor. SK-Hep1 cells infected with E1B/
19K (Panel A) or Ad-ME (Panel B) at indicated doses for 1 h were
incubated in the presence of indicated doses of the general caspase inhibitor
Z-VAD-FMK. Cells were harvested at 48 h after infection by trypsinization
and subjected to annexin V staining and flow cytometric analysis.Discussion
The data presented in the manuscript demonstrate that
overexpression of E3-11.6K enhances the cytolytic potency
of an adenovirus equivalent to that observed with a virus in
which E1B-19K gene is deleted. Morphological changes
including cell shrinkage and membrane blebbing, activation
of caspases 3 and 9, cleavage of PARP, DNA fragmentation,
and the ratio of ADP to ATP in Ad-ME-infected cells
indicated that apoptosis contributes to greater cell killing
observed due to E3-11.6K overexpression. Although the
extent and kinetics of cell death due to E3-11.6K over-
expression or E1B-19K deletion were similar, caspases 3
and 9 were activated to a lesser extent following E3-11.6K
overexpression. In addition, killing of cells infected with the
E3-11.6K overexpressing adenovirus was not effectivelyinhibited by the general caspase inhibitor Z-VAD-FMK.
These results suggest that cell death induced by viruses
with E3-11.6K overexpression is due to both caspase-
dependent and caspase-independent mechanisms.
Cells infected with E3-11.6K-overexpressing virus were
readily stained with both annexin V and PI, indicating that
cell membrane integrity was compromised following E3-
11.6K overexpression. Positive staining by both annexin V
and PI occurs during late stages of apoptosis and in necrosis
(Vermes et al., 2000). PI staining even in cells infected with
E1B/19K, which has been shown to induce apoptosis
(Marcellus et al., 1996), suggests that loss of membrane
integrity may occur even during early stages of apoptosis of
adenovirus-infected cells. Similar positive staining with PI
was observed in cells undergoing apoptosis following infec-
tion with a replication-defective adenovirus vector encoding
human p53 (our unpublished observations) or with Rubella
virus (Pugachev and Frey, 1998). Although these findings do
not rule out the possible contribution of necrosis due to E3-
11.6K overexpression, they suggest that annexin V staining
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necrosis in adenovirus-infected cells.
Involvement of apoptosis in cells overexpressing E3-
11.6K was indicated by activation of both caspases 3 and 9,
cleavage of PARP, DNA fragmentation, and slight inhibition
of cell killing by Z-VAD-FMK. It is well known that
effective execution of apoptosis requires the activation of
caspases. However, in several instances, caspase inhibitors
such as Z-VAD-FMK do not inhibit cell death because death
signaling occurs through basal caspase activities or caspase-
independent processes (Egger et al., 2003; Nagy and
Mooney, 2003). Previously, based on the morphological
features of infected cells, necrotic cell death was suggested
due to E3-11.6K expression (Tollefson et al., 1996b). Z-
VAD-FMK-resistant, caspase-independent cell killing ob-
served due to E3-11.6K overexpression in this study could
also be due to necrosis in addition to apoptosis.
The molecular mechanisms by which E3-11.6K induces
cell death are not known. In adenovirus-infected cells, E3-
11.6K is synthesized in small quantities at early times after
infection, but produced at approximately 400-fold higher
levels at late stages of infection (Tollefson et al., 1992).
Significantly increased levels of E3-11.6K at late stages of
infection are driven by mRNAs that contain the viral major
late tripartite leader (Tollefson et al., 1992). Unlike the
wild-type adenovirus, viral mutants that lack E3-11.6K
form small plaques with progeny virions found intracellu-
larly, suggesting a role for E3-11.6K in viral release. E3-
11.6K is an integral membrane N-linked, O-linked palmi-
toylated (Hausmann et al., 1998) glycoprotein that is
localized to the nuclear membrane, endoplasmic reticulum,
and Golgi (Scaria et al., 1992). Electron microscopic
observations have indicated that the nuclei of cells infected
with an E3-11.6K-deleted virus become very swollen with a
large number of progeny viruses without disruption of the
nuclear or plasma membranes (Tollefson et al., 1996b).
Mutational analysis of E3-11.6K has suggested that E3-
11.6K needs to be present in the nuclear membrane for its
lytic function (Tollefson et al., 2003). Recent studies have
indicated that E3-11.6K binds to human MAD2B also
known as MAD2L2 and REV7 (Ying and Wold, 2003).
Human MAD2B is about 25% identical to human MAD2, a
spindle assembly checkpoint protein (Ying and Wold,
2003). Interestingly, cells that are stably transfected with
MAD2B are lysed more slowly after infection with wild-
type adenovirus than the parental cell line, suggesting that
E3-11.6K interaction with MAD2B has functional rele-
vance (Ying and Wold, 2003).
Cell death induced by E1B-19K-deleted viruses has been
characterized in greater detail. Studies have shown that
increased cytopathicity due to E1B-19K deletion is due to
the lack of a potent anti-apoptotic activity of E1B-19K in
infected cells. Infection of HeLa cells with mutant adeno-
virus lacking functional E1B-19K has been shown to result
in massive apoptosis that is dependent upon E1A expression
(Rao et al., 1992; White and Stillman, 1987; White et al.,1991). E1A induces apoptosis by both p53-dependent and
independent mechanisms (Chiou and White, 1997; Teodoro
et al., 1995). E1B-19K is a viral homolog of cellular anti-
apoptotic protein Bcl-2 (White, 1998) that blocks apoptosis
by multiple mechanisms, which include direct binding of
E1B-19K with pro-apoptotic proteins including Bax (Han
et al., 1998), Bak (Farrow et al., 1995), and Nbk/Bik (Han
et al., 1996). Consistent with E1B-19K’s role to prevent
premature apoptosis to facilitate viral replication, E1B-19K-
deleted viruses have been shown to replicate inefficiently in
certain cell types (Pilder et al., 1986). In agreement with the
data presented in the manuscript, during apoptosis induced
by infection of E1B-19K mutant viruses, caspases 3 and 9,
but not caspase 8, are activated (Cuconati et al., 2002).
Inhibition of cell killing by Z-VAD-FMK, which was
previously shown to inhibit E1A-induced apoptosis (Sabba-
tini et al., 1997), and blocking of E1A-induced apoptosis
and caspase activation by expression of E1B-19K (Sabbatini
et al., 1997) further support the idea that the role of E1B-
19K is to prevent apoptosis induced by E1A. Furthermore,
E1B-19K mutant viruses induced apoptosis in wild-type and
Bax- or Bak-deficient baby mouse kidney cells, but not in
those deficient in both Bax and Bak, indicating that the anti-
apoptotic activity of E1B-19K is targeting these two key
cellular pro-apoptotic proteins that are activated as an
antiviral response (Cuconati et al., 2002).
It has been hypothesized that during the late stages of
viral infection cycle E3-11.6K blocks the action of the E1B-
19K protein, thus sensitizing infected cells to apoptosis
(Tollefson et al., 1996b). If this hypothesis were to be
correct, one would expect similar modes of cell killing but
likely with different timing by viral mutants lacking E1B-
19K and those that overexpress E3-11.6K. However, the
data presented here that support that cell killing by E1B/
19K occurs predominantly by caspase-dependent apopto-
sis, whereas cell killing by Ad-ME is mediated by both
caspase-dependent and caspase-independent means suggest
that E3-11.6K may not simply antagonize E1B-19K func-
tion. In contrast to E1B-19K, E3-11.6K is expressed late in
the infection cycle to facilitate release of progeny virions
from infected cells (Tollefson et al., 1996b). Possible
interference in the normal function of MAD2B by E3-
11.6K to control mitosis and other aspects of cell cycle
(Ying and Wold, 2003), as well as other molecular mech-
anisms that are involved in lysis of infected cells due to E3-
11.6K, needs to be examined.Materials and methods
Cells lines
HEK 293 (Microbix, Toronto, ON, Canada), A549, and
SK-Hep1 (both fromATCC,Manassas, VA) were maintained
in Dulbecco’s modified Eagle’s medium with 10% fetal
bovine serum.
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Control viruses used in the study include previously
described viruses Ad5, dl309 (Jones and Shenk, 1979),
dl327 (Thimmappaya et al., 1982). E1B/19K (Marcellus
et al., 1996) was a kind gift from Phil Branton (McGill
University, Montreal). To generate Ad-ME, which encodes
E3-11.6K under the control of adenovirus type 2 major late
promoter in the E3 region, desired sequences were amplified
by PCR. Viral plasmid was generated by homologous
recombination in bacteria (Chartier et al., 1996). Viruses
obtained following transfection of HEK-293 cells with
linearized viral plasmids were amplified and purified by
column chromatography as described (Huyghe et al., 1995).
The viral preparations were characterized by restriction
enzyme digestion and DNA sequencing across sequences
encoding E3-11.6K and adenovirus type 2 major late
promoter.
Immunoblots
Cell lysates were subjected to electrophoresis on sodium
dodecyl sulfate–10% polyacrylamide gels (Invitrogen,
Carlsbad, CA) and transferred to nitrocellulose. The nitro-
cellulose blots were blocked in 20% nonfat dry milk in Tris-
buffered saline containing 0.05% Tween 20 (TBST) for 30–
60 min. The blots were then incubated with primary anti-
bodies diluted in TBST containing 5% nonfat dry milk and
incubated for 2 h at room temperature. Rabbit polyclonal
anti-E3-11.6K, generated as described before (Tollefson
et al., 1992), and anti-caspase 9 (Cell Signaling, Beverly,
MA) and monoclonal anti-caspase 3 (Alexis Biochemicals,
San Diego, CA) anti-h actin antibody (Sigma, St. Louis,
MO), and goat polyclonal anti-caspase 8 and anti-PARP1
(both from Santa Cruz) were used. The blots were washed
with TBST and incubated with appropriate secondary anti-
bodies conjugated with horseradish peroxidase (for E3-
11.6K and PARP) (Jackson Immunoresearch Laboratories,
West Grove, PA) or infrared dye (Rockland Immunoche-
micals, Gilbertsville, PA) in TBST containing 5% nonfat dry
milk. The immunoreactive bands were visualized by Super-
Signal West Pico Chemiluminescent substrate (Pierce,
Rockford, IL) or Odyssey Infrared Imaging System (LI-
COR Biosciences, Lincoln, NE).
Determination of cell viability
Cell viability was performed using MTS reagent (Pro-
mega) as described (Howe et al., 2000).
Annexin V staining
Cells were trypsinized and stained with Annexin V-FITC
(Boehringer Mannheim, Indianapolis, IN) followed by flow
cytometric analysis according to instructions from the manu-
facturer. For double staining with annexin V–FITC and PI,
A. Zou et al. / VirolPI was added at a final concentration of 1 Ag/ml before flow
cytometry.
Caspase assays
For the determination of caspase activity, 1  106 cells
were lysed in 50 Al of cell lysis buffer (Clontech Labora-
tories, Palo Alto, CA). To the cell lysates, 20 mM appro-
priate caspase substrate was added and incubated at 37 jC
for 1 h. Caspase substrates used were Ac-DEVD-AFC for
caspase 3 and Ac-LEHD-AFC for caspase 9 (Enzyme
Systems, Livermore, CA). Fluorescence was then measured
on a Cytofluor fluorescence multiwell plate reader (Pers-
pective Biosystems) with 400-nm excitation and 505-nm
emission filters. Activities were expressed in arbitrary
fluorescence units.
Determination of DNA fragmentation
DNA fragmentation was assessed by harvesting cells at
48 h postinfection and low molecular weight DNA was
isolated by a modified Hirt extraction procedure (Marcellus
et al., 1996). Extracted DNA was treated with RNAse and
analyzed on 1.2% agarose gel stained with ethidium
bromide.
Measurement of ADP/ATP ratio
The ADP/ATP ratio as an indicator of cell proliferation,
necrosis, and apoptosis (Bradbury et al., 2000) was mea-
sured using ApoGlow adenylate nucleotide ratio assay kit
from Cambrex Bioscience Rockland, Inc. (Rockland, ME)
according to instructions provided by the supplier.
Caspase inhibition assay
Cells were infected with appropriate viruses for 24 h and
treated with general caspase inhibitor (Z-Val-Ala-Asp-FMK
[Z-VAD-FMK]) (Enzyme Systems Products) at 25 or 50 AM.
Cells were harvested 48 h after Z-VAD-FMK treatment and
analyzed for cell death by annexin V staining assay.Acknowledgments
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